Available medical treatments for symptomatic endometriosis act by inhibiting ovulation, reducing serum oestradiol levels, and suppressing uterine blood flows. To this aim, several drugs can be used, with a similar magnitude of effect, in term of pain relief, independently of the mechanism of action. Conversely, safety, tolerability, and cost differ. Medications for endometriosis can be categorised into low-cost drugs, including OCs and most progestogens, and high cost drugs, including dienogest and GnRH agonists. As the individual response to different drugs is variable, a stepwise approach is suggested, starting with OCs or low-cost progestogens, and stepping up to high-cost drugs only in case of inefficacy or intolerance. Oral contraceptives may be used in women with dysmenorrhoea as their main complaint, and when only superficial peritoneal implants or ovarian endometriomas < 5 cm are present, while progestogens should be preferred in women with severe deep dyspareunia and when infiltrating lesions are identified.

Medical treatment of endometriosis-related pain / P. Vercellini, L. Buggio, M.P. Frattaruolo, A. Borghi, D. Dridi, E. Somigliana. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL OBSTETRICS & GYNAECOLOGY. - ISSN 1521-6934. - 51:(2018 Aug), pp. 68-91. [10.1016/j.bpobgyn.2018.01.015]

Medical treatment of endometriosis-related pain

P. Vercellini
Primo
;
L. Buggio
Secondo
;
M.P. Frattaruolo;E. Somigliana
Ultimo
2018

Abstract

Available medical treatments for symptomatic endometriosis act by inhibiting ovulation, reducing serum oestradiol levels, and suppressing uterine blood flows. To this aim, several drugs can be used, with a similar magnitude of effect, in term of pain relief, independently of the mechanism of action. Conversely, safety, tolerability, and cost differ. Medications for endometriosis can be categorised into low-cost drugs, including OCs and most progestogens, and high cost drugs, including dienogest and GnRH agonists. As the individual response to different drugs is variable, a stepwise approach is suggested, starting with OCs or low-cost progestogens, and stepping up to high-cost drugs only in case of inefficacy or intolerance. Oral contraceptives may be used in women with dysmenorrhoea as their main complaint, and when only superficial peritoneal implants or ovarian endometriomas < 5 cm are present, while progestogens should be preferred in women with severe deep dyspareunia and when infiltrating lesions are identified.
endometriosis; dysmenorrhoea; dyspareunia; pelvic pain; oral contraceptives; progestogens; dienogest; GnRH agonists; GnRH antagonists
Settore MED/40 - Ginecologia e Ostetricia
ago-2018
15-feb-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Vercellini 2018 Best Pract Medical Tp.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 993.14 kB
Formato Adobe PDF
993.14 kB Adobe PDF Visualizza/Apri
BestPracticeClinicalResearch_MedicalTreatmentEndometriosis_2018.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 513.61 kB
Formato Adobe PDF
513.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/550301
Citazioni
  • ???jsp.display-item.citation.pmc??? 43
  • Scopus 103
  • ???jsp.display-item.citation.isi??? 81
social impact